Skip to main content

QuantideX® CDx Accelerating the Drug Development Journey


Whitepapers Summary

Accelerating the drug development whitepaper cover

The QuantideX technology can be adapted to monitor disease burden in diseases requiring highly sensitive detection and/or quantitation across multiple nucleic acid targets. It can also be utilized for designing high performing, efficient, and simplified kits for genetic targets with unmet biomarker development and CTA needs.

Request Literature

To access this literature content please fill out the form below.